Literature DB >> 2571873

Efficacy of tests used to monitor rheumatoid arthritis.

B S Bull1, J C Westengard, M Farr, P A Bacon, P J Meyer, J Stuart.   

Abstract

The relative efficacy of clinical and laboratory tests used to monitor disease activity in rheumatoid arthritis was determined by consensus analysis in a study of 21 patients treated for 6 months. Erythrocyte sedimentation rate (ESR), which is influenced by the anaemia of chronic disease and by variation in the blood concentration of acute-phase proteins, was the most effective single test. ESR was a better guide to disease severity than measurement of plasma viscosity, serum C-reactive protein, and serum orosomucoid--tests that reflect the blood concentration of acute-phase proteins only. Clinical tests performed poorly unless combined with laboratory data in a numerical index. Consensus analysis can be used to assess the efficacy of clinical and laboratory tests and to identify redundant tests.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571873     DOI: 10.1016/s0140-6736(89)90965-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  Evaluation of a 200 mm long vacuum aspiration tube for measurement of erythrocyte sedimentation rate.

Authors:  M Caswell; J Stuart
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

2.  Assessment of Diesse Ves-matic automated system for measuring erythrocyte sedimentation rate.

Authors:  M Caswell; J Stuart
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

3.  Plasma viscosity in inflammatory bowel disease.

Authors:  A J Lobo; S C Jones; L D Juby; A T Axon
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

4.  Plasma viscosity and erythrocyte sedimentation rate in inflammatory and non-inflammatory rheumatic disorders.

Authors:  G J Dinant; J W van Wersch; H S Goei The; J A Knottnerus
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

5.  Intra-articular steroids: confounder of clinical trials.

Authors:  H G Taylor; P D Fowler; M J David; P T Dawes
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

6.  Revising DAS28 scores for remission in rheumatoid arthritis.

Authors:  Claire Sheehy; Verity Evans; Heather Hasthorpe; Chetan Mukhtyar
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

7.  Radionuclide imaging with human polyclonal immunoglobulin (Tc-HIG) and bone scan in patients with rheumatoid arthritis and serum-negative polyarthritis.

Authors:  G Gerasimou; E Moralidis; E Papanastasiou; G Liaros; T Aggelopoulou; E Triantafyllidou; N Lytras; L Settas; A Gotzamani-Psarrakou
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

8.  Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

Authors:  D M van der Heijde; M A van't Hof; P L van Riel; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

9.  Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset.

Authors:  M H de Bois; M L Westedt; J W Arndt; K S Wiarda; E A van der Velde; E K Pauwels; F C Breedveld
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

10.  Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity.

Authors:  Dong Jin Go; Kichul Shin; Han Joo Baek; Seong Wook Kang; Young Mo Kang; Jae Bum Jun; Yun Jong Lee; Sung Hwan Park; Yeong Wook Song
Journal:  Clin Rheumatol       Date:  2017-10-08       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.